ClinicalTrials.Veeva

Menu

Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM (RAPID XT)

D

Dr Ange FERRACCI

Status and phase

Completed
Phase 4

Conditions

Atrial Fibrillation

Treatments

Device: ICM Implantation

Study type

Interventional

Funder types

Other

Identifiers

NCT00789139
RAPIDXT

Details and patient eligibility

About

Post Marketing study, Interventional, Prospective, non randomised

Describe how the MD is using the information of the ICM in addition of standard FU(clinical exam and holter 24h)post AF ablation(1 year FU).

Enrollment

47 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • AF thermoablation indication
  • Informed Consent signed,
  • Age between 18 & 75

Exclusion criteria

  • Participation to other clinical trial
  • Non compliant patient
  • Pregnant women
  • Left Atrial thrombus
  • Endocarditis, infection

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

47 participants in 1 patient group

AF monitoring by ICM
Other group
Description:
Only one arm
Treatment:
Device: ICM Implantation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems